TF
Terence Flynn Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
63
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $125 |
21%
upside
| 1 | -1.7% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $596 |
35%
upside
| 1 | +2.5% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $1,313 |
42%
upside
| 1 | +5.8% |
0
%
| 5 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $270 |
30%
upside
| 1 | +5% |
0
%
| 5 Feb ‘26 2 months ago |
|
|
|
Equal-Weight
Maintained
| $309 |
13%
downside
| 1 | – |
–
| 4 Feb ‘26 2 months ago |
|
|
|
Overweight
Upgraded
| $262 |
12%
upside
| 2 | +8.2% |
0
%
| 28 Jan ‘26 2 months ago |
|